Kisqali 400 MG daily dose 42S
Ended Awarded
- Contract number
- SPE2DB25FBCJ8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,526
Award facts
- Contract value 100% obligated
- $30,526.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,526.21 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Kisqali 400 mg daily dose tablets (42-count units). This is a non-set-aside competitive award with an ultimate completion date of July 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location. Kisqali is a brand-name oncology medication used in breast cancer treatment, reflecting the company's role in supplying specialized pharmaceutical products to support federal healthcare needs.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to military healthcare programs and other federal healthcare systems. The firm's consistent receipt of competitive delivery orders through this vehicle demonstrates its established capability to fulfill federal medical procurement requirements and support the Defense Health Agency and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DB25FBCJ8?
SPE2DB25FBCJ8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FBCJ8 worth?
The government has obligated $30,526 on SPE2DB25FBCJ8.
Is contract SPE2DB25FBCJ8 an order under another contract?
Yes. SPE2DB25FBCJ8 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBCJ8 competed?
The extent of competition for SPE2DB25FBCJ8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award